Ralph Dagostino

Dr. Ralph Dagostino

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in The Lancet
Verified
Journal Article
Closed access
VTVinod H Thourani
Vinod H Thourani
SKSusheel Kodali
Susheel Kodali
RMRaj R Makkar
Raj R Makkar
HHHoward C Herrmann
Howard C Herrmann
MWMathew Williams
Mathew Williams
MLMartin B Leon
Martin B Leon

1 May 2007 in Circulation
Verified
Journal Article
Closed access
RDRalph Dagostino
Ralph Dagostino

1 May 2001 in The American Journal of Cardiology
Verified
Journal Article
Closed access
LDLuc Djousse
Luc Djousse
DLDaniel Levy
Daniel Levy
LCL.ADrienne Cupples
L.ADrienne Cupples
JEJane C Evans
Jane C Evans
RDRalph Dagostino
Ralph Dagostino
RER.CUrtis Ellison
R.CUrtis Ellison

1 March 2014 in The Lancet Oncology
Verified
Journal Article
Closed access
IGIan M Gralnek
Ian M Gralnek
PSPeter D Siersema
Peter D Siersema
ZHZamir Halpern
Zamir Halpern
OSOri Segol
Ori Segol
AMAlaa Melhem
Alaa Melhem
DRDouglas K Rex
Douglas K Rex

26 October 2004 in Circulation
Verified
Journal Article
Closed access
PDF file
NSNaveed Sattar
Naveed Sattar
KWKen Williams
Ken Williams
ASAllan D. Sniderman
Allan D. Sniderman
RDRalph D’aGostino
Ralph D’aGostino
SHSteven M. Haffner
Steven M. Haffner
RDRalph Dagostino
Ralph Dagostino
Background— The metabolic syndrome (MetS) as defined by the National Cholesterol Education Panel definition has been proposed as an indicator of cardiovascular disease risk. Both apolipoprotein (apo)B and non-HDL cholesterol (NHDLC) have been proposed as an additional indicator to identify patients at higher risk in MetS patients. Methods and Results— We studied 1522 individuals in the Insulin Resistance Atherosclerosis Study (IRAS) who were 40 to 69 years of age and from 3 ethnic groups. Their anthropometric measures, lipids, apoB, C-reactive protein, fibrinogen, plasminogen activator inhibitor-1, fasting and post-glucose load glucose, and insulin concentrations were measured, and insulin sensitivity was determined by intravenous glucose tolerance test. Differences in risk parameters in individuals with hyper-apoB/normo-NHDLC, and normo-apoB/hyper-NHDLC were compared in all IRAS subjects and again in those with MetS. In both cases, despite anticipated lower LDL cholesterol, the hyper-apoB/normo-NHDLC group had elevated risk indicated by greater waist circumference (both P <0.05) and fasting insulin ( P <0.01) and lower insulin sensitivity ( P <0.001). They also had higher C-reactive protein ( P <0.05). Moreover, the Spearman correlation of apoB was significantly stronger ( P <0.05) in the direction of greater associated risk than that of NHDLC with body mass index, waist circumference, systolic blood pressure, 2-hour glucose, fasting glucose, fasting insulin, 2-hour insulin, insulin sensitivity, C-reactive protein, fibrinogen, and plasminogen activator inhibitor-1. Conclusions— In conclusion, apoB is more closely associated with central adiposity, insulin resistance, thrombosis, and inflammation than NHDLC. Our data suggest that apoB is a better candidate risk parameter than NHDLC for identifying a subgroup of individuals with or without MetS with elevated cardiovascular risk.

9 January 2012 in International Journal of Health Geographics
Verified
Journal Article
Open access
PDF file
ALAngela Liese
Angela Liese
Robin PuettRobin Puett
Robin Puett
ALArchana P Lamichhane
Archana P Lamichhane
MNMichele D Nichols
Michele D Nichols
DDDana Dabelea
Dana Dabelea
EMElizabeth J Mayer-Davis
Elizabeth J Mayer-Davis
European ecologic studies suggest higher socioeconomic status is associated with higher incidence of type 1 diabetes. Using data from a case-control study of diabetes among racially/ethnically diverse youth in the United States (U.S.), we aimed to evaluate the independent impact of neighborhood characteristics on type 1 diabetes risk. Data were available for 507 youth with type 1 diabetes and 208 healthy controls aged 10-22 years recruited in South Carolina and Colorado in 2003-2006. Home addresses were used to identify Census tracts of residence. Neighborhood-level variables were obtained from 2000 U.S. Census. Multivariate generalized linear mixed models were applied. Controlling for individual risk factors (age, gender, race/ethnicity, infant feeding, birth weight, maternal age, number of household residents, parental education, income, state), higher neighborhood household income (p = 0.005), proportion of population in managerial jobs (p = 0.02), with at least high school education (p = 0.005), working outside the county (p = 0.04) and vehicle ownership (p = 0.03) were each independently associated with increased odds of type 1 diabetes. Conversely, higher percent minority population (p = 0.0003), income from social security (p = 0.002), proportion of crowded households (0.0497) and poverty (p = 0.008) were associated with a decreased odds. Our study suggests that neighborhood characteristics related to greater affluence, occupation, and education are associated with higher type 1 diabetes risk. Further research is needed to understand mechanisms underlying the influence of neighborhood context.